Asset
Treprostinil
United Therapeutics Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (6)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00067041 | phase2_3 | terminated | 2003-03-01 | 2003-12-01 | United Therapeutics | Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft |
| NCT00004497 | phase3 | completed | 1998-10-01 | — | United Therapeutics | Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension |
| NCT02847260 | phase4 | completed | 2012-04-01 | 2014-03-01 | United Therapeutics | Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) |
| NCT00439946 | phase4 | terminated | 2007-02-01 | 2009-09-01 | United Therapeutics | Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH |
| NCT00494533 | phase4 | terminated | 2005-03-01 | 2005-10-01 | United Therapeutics | Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension |
FDA applications (4)
| Application | Type | Applicant |
|---|---|---|
| NDA 021272 | NDA | UNITED THERAPEUTICS CORP |
| NDA 022387 | NDA | UNITED THERAPEUTICS CORP |
| NDA 208276 | NDA | UNITED THERAPEUTICS CORP |
| NDA 214324 | NDA | UNITED THERAPEUTICS CORP |
Marketed products (18)
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- REMODULIN
- TYVASO
- TYVASO DPI
- TYVASO DPI
- TYVASO DPI
- TYVASO DPI
- TYVASO DPI